MCPHY Fundamental Analysis - MCPHY ENERGY SA

Fundamental Rating

Taking everything into account, MCPHY scores 2 out of 10 in our fundamental rating. MCPHY was compared to 109 industry peers in the Machinery industry. Both the profitability and financial health of MCPHY have multiple concerns. MCPHY is quite expensive at the moment. It does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

MCPHY had negative earnings in the past year.

MCPHY had a negative operating cash flow in the past year.

MCPHY had negative earnings in each of the past 5 years.

In the past 5 years MCPHY always reported negative operating cash flow.

1.2 Ratios

With a Return On Assets value of -28.85%, MCPHY is not doing good in the industry: 94.50% of the companies in the same industry are doing better.

With a Return On Equity value of -53.75%, MCPHY is not doing good in the industry: 90.83% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
ROA	-28.85%
ROE	-53.75%
ROIC	N/A

ROA(3y)-19.55%

ROA(5y)-16.85%

ROE(3y)-31.9%

ROE(5y)-27.63%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Gross Margin of MCPHY (14.75%) is worse than 90.83% of its industry peers.

MCPHY's Gross Margin has declined in the last couple of years.

The Profit Margin and Operating Margin are not available for MCPHY so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	14.75%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-31.69%

GM growth 5Y-19.17%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

MCPHY does not have a ROIC to compare to the WACC, probably because it is not profitable.

MCPHY has about the same amout of shares outstanding than it did 1 year ago.

The number of shares outstanding for MCPHY has been increased compared to 5 years ago.

Compared to 1 year ago, MCPHY has a worse debt to assets ratio.

2.2 Solvency

MCPHY has an Altman-Z score of -0.85. This is a bad value and indicates that MCPHY is not financially healthy and even has some risk of bankruptcy.

MCPHY has a Altman-Z score of -0.85. This is amonst the worse of the industry: MCPHY underperforms 81.65% of its industry peers.

MCPHY has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.

The Debt to Equity ratio of MCPHY (0.03) is better than 90.83% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.03
Debt/FCF	N/A
Altman-Z	-0.85

ROIC/WACCN/A

WACC7.47%

2.3 Liquidity

MCPHY has a Current Ratio of 1.56. This is a normal value and indicates that MCPHY is financially healthy and should not expect problems in meeting its short term obligations.

MCPHY has a Current ratio (1.56) which is in line with its industry peers.

MCPHY has a Quick Ratio of 1.43. This is a normal value and indicates that MCPHY is financially healthy and should not expect problems in meeting its short term obligations.

The Quick ratio of MCPHY (1.43) is better than 74.31% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.56
Quick Ratio	1.43

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for MCPHY have decreased strongly by -24.41% in the last year.

The Revenue has grown by 16.89% in the past year. This is quite good.

MCPHY shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 18.75% yearly.

EPS 1Y (TTM)-24.41%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-29.49%

Revenue 1Y (TTM)16.89%

Revenue growth 3Y11.09%

Revenue growth 5Y18.75%

Sales Q2Q%8.25%

3.2 Future

MCPHY is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 22.79% yearly.

MCPHY is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 51.36% yearly.

EPS Next Y-2.53%

EPS Next 2Y8.21%

EPS Next 3Y14.96%

EPS Next 5Y22.79%

Revenue Next Year66.02%

Revenue Next 2Y72.07%

Revenue Next 3Y95.14%

Revenue Next 5Y51.36%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MCPHY. In the last year negative earnings were reported.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for MCPHY. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

MCPHY's earnings are expected to grow with 14.96% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y8.21%

EPS Next 3Y14.96%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for MCPHY!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

MCPHY ENERGY SA

EPA:MCPHY (8/8/2024, 7:00:00 PM)

2.32

+0 (+0.22%)

Chartmill FA Rating

GICS SectorIndustrials

GICS IndustryGroupCapital Goods

GICS IndustryMachinery

Earnings (Last)07-30 2024-07-30

Earnings (Next)N/A N/A

Inst OwnersN/A

Inst Owner ChangeN/A

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap67.60M

Revenue(TTM)18.77M

Net Income(TTM)-47.43M

Analysts41.82

Price Target3 (29.31%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)-3.96%

PT rev (3m)-39.64%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)-0.31%

EPS NY rev (3m)-0.31%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)31.66%

Revenue NY rev (3m)31.66%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	3.6
P/FCF	N/A
P/OCF	N/A
P/B	0.77
P/tB	0.8
EV/EBITDA	N/A

EPS(TTM)-1.7

EYN/A

EPS(NY)-1.69

Fwd EYN/A

FCF(TTM)-2.55

FCFYN/A

OCF(TTM)-1.76

OCFYN/A

SpS0.64

BVpS3.03

TBVpS2.88

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-28.85%
ROE	-53.75%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	14.75%
FCFM	N/A

ROA(3y)-19.55%

ROA(5y)-16.85%

ROE(3y)-31.9%

ROE(5y)-27.63%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-31.69%

GM growth 5Y-19.17%

F-Score3

Asset Turnover0.11

Health

		Industry Rank	Sector Rank
Debt/Equity	0.03
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	412.64%
Cap/Sales	121.88%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	1.56
Quick Ratio	1.43
Altman-Z	-0.85

F-Score3

WACC7.47%

ROIC/WACCN/A

Cap/Depr(3y)378.1%

Cap/Depr(5y)233.61%

Cap/Sales(3y)63.29%

Cap/Sales(5y)38.6%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-24.41%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-29.49%

EPS Next Y-2.53%

EPS Next 2Y8.21%

EPS Next 3Y14.96%

EPS Next 5Y22.79%

Revenue 1Y (TTM)16.89%

Revenue growth 3Y11.09%

Revenue growth 5Y18.75%

Sales Q2Q%8.25%

Revenue Next Year66.02%

Revenue Next 2Y72.07%

Revenue Next 3Y95.14%

Revenue Next 5Y51.36%

EBIT growth 1Y-30.49%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year8.4%

EBIT Next 3Y20.22%

EBIT Next 5Y17.79%

FCF growth 1Y-187.25%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-205.02%

OCF growth 3YN/A

OCF growth 5YN/A

MCPHY ENERGY SA / MCPHY.PA FAQ

Can you provide the ChartMill fundamental rating for MCPHY ENERGY SA?

ChartMill assigns a fundamental rating of 2 / 10 to MCPHY.PA.

What is the valuation status of MCPHY ENERGY SA (MCPHY.PA) stock?

ChartMill assigns a valuation rating of 0 / 10 to MCPHY ENERGY SA (MCPHY.PA). This can be considered as Overvalued.

Can you provide the profitability details for MCPHY ENERGY SA?

MCPHY ENERGY SA (MCPHY.PA) has a profitability rating of 0 / 10.

How financially healthy is MCPHY ENERGY SA?

The financial health rating of MCPHY ENERGY SA (MCPHY.PA) is 3 / 10.

MCPHY ENERGY SA (MCPHY.PA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

MCPHY ENERGY SA / MCPHY.PA FAQ

Can you provide the ChartMill fundamental rating for MCPHY ENERGY SA?

What is the valuation status of MCPHY ENERGY SA (MCPHY.PA) stock?

Can you provide the profitability details for MCPHY ENERGY SA?

How financially healthy is MCPHY ENERGY SA?